See also this year's filing and all EDGAR filings for this company.
PDF Report 0001533040_2026_Phio_Pharmaceuticals_Corp.pdf
Logs
Graph
Absolute values for 0001533040, Phio Pharmaceuticals Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 21,476,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 435,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 905,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,311,204 |
| 9 | ResearchAndDevelopmentExpense | 4,357,460 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,430 |
| 12 | remainder_NetIncome | 421,287 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,487,000 |
| 1 | Liabilities | 1,340,000 |
| 2 | Expenses | 8,668,664 |
| 3 | Revenues | 1,430 |
| 4 | StockholdersEquity | 20,147,000 |
| 5 | NetIncome | -8,245,947 |
| 6 | ComprehensiveNetIncome | -8,245,947 |
| 7 | BaseVar | 15,959,190 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.13 |
| 9 | EconomicCapitalRatio | 3.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
